Abstract. The polymerase chain reaction-based microtiter plate hybridization (PCR-MPH) assay was utilized for a DNA diagnosis of Plasmodium vivax malaria, which has recently reemerged in the Republic of Korea. The subjects were 18 parasite-proven patients and 5 healthy controls. Follow-up blood samples were collected from 4 patients after a standard course of treatment. Polymerase chain reaction and electrophoresis of all the patients' blood showed a prominent band at the 138 base pair area, but not in the controls or after treating the patients. Hybridization of the PCR products with known species-specific probes of the 18S rRNA of various malaria species revealed strong positive reactions against the Plasmodium vivax-specific probe (absorbance 1.30-1.90 at 405 nm) in all of the patients. The absorbance was positively correlated with the degree of blood parasitemia, but with a borderline significance. Sequencing of the probe region of the Korean P. vivax revealed no significant variations from the typical P. vivax. The results show that the PCR-MPH is a highly useful technique for the DNA diagnosis of Korean vivax malaria.
INTRODUCTION
Plasmodium vivax, the only known species of malaria indigenous to the Republic of Korea, was highly prevalent until the 1970s when it disappeared. 1, 2 In 1993, however, a soldier working in the northern part of Kyonggi-do Province, who had never been abroad, developed fever and was diagnosed with P. vivax malaria. 2 Since then, exponentially increasing numbers of malaria patients have been occurring each year: 25 cases in 1994, 107 in 1995, 356 in 1996, 1,724 in 1997, 3 ,932 in 1998, and 3,621 in 1999. 3, 4 Thus, P. vivax malaria has become an important reemerging disease in the Republic of Korea. Other than this type of malaria, tropical and quartan malaria have been diagnosed among Korean travelers who had been to tropical and subtropical countries. 5 The diagnosis of malaria is usually based upon the identification of parasites from Giemsa or Wright-stained thick or thin blood films. This method is simple and does not require sophisticated equipment. However, it is time-consuming and at times species diagnosis is difficult when the patient is mixed-infected, modified by a drug treatment, or reveals a low grade parasitemia. 6 As an alternative to the morphological diagnosis, a dipstick test detecting a blood stage antigen known as histidine-rich protein II was introduced in Plasmodium falciparum infection, 7 but it is not applicable to other species of malaria. The serological diagnosis has also been tried to detect antibodies, but it cannot discriminate past and present infections. 8, 9 To overcome these difficulties, several researchers have developed DNA probe-based, RNA-probe based or polymerase chain reaction (PCR)-based procedures in order to detect malarial genes. [8] [9] [10] [11] [12] [13] Among them, the PCR-based microtiter plate hybridization (MPH) was reported to be a simple but highly useful technique for a DNA diagnosis of different species of malaria. [11] [12] [13] However, more trials are needed to verify the usefulness and feasibility of the MPH technique. After the reemergence of P. vivax malaria in the Republic of Korea, the diagnosis of patients has usually been based on the examination of blood films, 3 and DNA diagnosis has never been tried. Thus, in the present study, we evaluated the usefulness of the MPH technique in the genetic diagnosis of Korean P. vivax malaria.
MATERIALS AND METHODS
Patients. Eighteen P. vivax patients proven by parasites on blood films and 5 healthy controls were subjected to study. The patients consisted of 16 soldiers (males, 20-23 years old), who were admitted to a military hospital located in a northern part of suburban Seoul, and 2 civilians aged 5 years (female) and 19 years (male), who were admitted to the Seoul National University Hospital and Seoul Gangye Paik Hospital, respectively. After collecting the blood samples, all of the patients were treated with chloroquine for 3 days (10 mg/kg plus 5 mg/kg on the first day and 5 mg/kg per day for the following 2 days) and then primaquine for 14 days (15 mg daily). Follow-up blood samples were collected from 4 patients at Days 3-27 after the last dose of primaquine; other patients were not cooperative in followup studies.
Parasite density. The degree of parasitemia was determined by counting the total number of malaria-infected red blood cells (RBC) per 500 high power fields (x 1,000) in thin blood films. The percent parasitemia was calculated by dividing it by the total number of RBCs, and was expressed as the parasite density per L blood.
Target sequences of malaria parasites. It is well known that the plasmodial genes encoding 18S rRNA contain species-specific regions: P. vivax, 14 P. falciparum, 15 Plasmodium malariae, 16 Plasmodium ovale, 12 and Plasmodium ovalevariant (showing variations at the probe region, reported from Vietnam). 17 The oligonucleotide primer set (primer MPH-1; 5Ј-CAGATACCGTCGTAATCTTA-3Ј, and primer MPH-2; 5Ј-CCAAAGACTTTGATTT CTCAT-3Ј) cross-reactive for P. vivax, P. falciparum, and P. malariae was used as described previously. 12, 13 Species-specific probes (P. vivax; 14 5Ј-TAAACTCCGAA-GAGAAAATTC-3Ј, P. falciparum; 15 5Ј-GTCACCTCGAAA-GATGACTT-3Ј, P. malariae;
16 5Ј-ACTCATATA TAA-GAATGTCTC-3, P. ovale; 12 5Ј-AATTTCCCCGAAAGGAA TTTTC-3Ј, and P. ovale-variant; 17 5Ј-GAAATTTCCAAAAG-GAATTTTC-3Ј) were prepared in the plasmid pUC-Sfiϫ2 as described previously. 11 The plasmid pUC-Sfiϫ2, containing two identical SfiI linkers (27 mer; Boeringer Manheim, Manheim, Germany) in the same orientation between the SmaI and HincII sites of pUC118, was used as a cloning vector for the probe. 11 The procedure set forth by Kimura and others 13 was used to immobilize the probes on plate wells.
Treatment of blood samples. Ten microliters of heparinized blood were suspended in 150 L phosphate-buffered saline (PBS) containing 10 U/mL of nystatin and 25 g/mL of gentamycin. The samples were kept at 4ЊC until use. They were hemolyzed by adding 18 L of 0.2% saponin/PBS (final concentration about 0.02%) and incubated at room temperature for 5 min. The mixture was centrifuged at 10,000 rpm for 10 min and the supernatant was discarded. The pellet was re-suspended with 200 L PBS, vortexed, and centrifuged again under the same conditions. The destruction and proteolysis of the parasites were carried out by adding to the pellet 40 L of the lysis solution, 13 together with one drop of mineral oil followed by incubation at 60ЊC for 20 min. The mixture was incubated at 95ЊC for 10 min to inactivate the proteinase K, and then cooled to 50ЊC.
PCR amplification. The sample was spun down and mixed with 10 L of the PCR reagent mixture containing 10 mM Tris-HCl (pH 8.9), 1.5 mM MgCl 2 , 500 g of bovine serum albumin per mL, 0.1% Triton X-100, 5 g each of primer MPH-1 and primer MPH-2 per mL, 1 mM deoxynucleoside triphosphates, and 100 U of Thermus thermophilus (Tth) polymerase (Toyobo, Osaka, Japan). The mixture was subjected to 30 cycles of PCR in a thermal cycler (Combi Thermal Reactor TR-2; Hybaid, Teddington, Middlesex, UK). The conditions for PCR amplification were as follows: denaturation at 91ЊC for 30 sec, annealing at 52ЊC for 60 sec, and extension at 72ЊC for 60 sec. After amplification, the tubes were gradually cooled to room temperature, and the amplified DNA was denatured by heating at 95ЊC for 10 min followed by rapid cooling on ice for 10 min.
Hybridization and colorization. Microtiter plate wells coated with probes specific for P. vivax, P. falciparum, P. malariae, P. ovale, and P. ovale-variant were filled with 100 L/well of 5x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate). After 5 L each of the PCR products were placed in the wells and incubated at 60ЊC for 1 hr, the solution was removed, and the wells were washed three times with 200 L/well of 2x SSC. Then 100 L of alkaline phosphatase-labeled streptavidin (Bethesda Research Lab., Bethesda, MD), diluted to 1:1,000 with solution 1 (0.1 M TrisHCl pH 7.5, 0.1 M NaCl, 2 mM MgCl 2 , and 0.05% Triton X-100), was added to each well.
The wells were washed three times with 300 L of solution 1, and 100 L of PNPP solution (1 M diethanolamine pH 9.8, 0.5 mM MgCl 2 , and 10 mM para-nitrophenyl phosphate) was added to each well as the substrate. Then the mixture was incubated at 25ЊC for 30 min. The color development was measured using an enzyme immunoassay reader (MPR-A4, TOSOH, Tokyo, Japan) at 405 nm. A positive value was identified where the optical density (OD) was higher than the double of the healthy controls (0.083 Ϯ 0.009, n ϭ 66).
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Agarose gel electrophoresis. The PCR products were analyzed by electrophoresis on 1.2% agarose gel (Seakem LE agarose, FMC Bioproducts, Rockland, ME) in 1x TBE running buffer (0.89 M Tris, 0.89M boric acid, and 0.02 M EDTA). Five microliters of the PCR products were added to the lanes of the gel, and the gels were run at 100 V for 30 min. The gels were stained with ethidium bromide (5 L/ ml) for 5 min, and soaked in distilled water. Photographs of the gels were taken using a UV transilluminator. The size of the product was estimated by comparison with 123 and 246 base pair (bp) ladder DNA size markers.
Partial sequencing of 18S rRNA of Korean P. vivax. DNA fragments of the 138 bp area (the target region of MPH) were amplified using the primers MPH-1 and MPH-2, and purified by a microconcentrator (Centricon, Amicon, Japan). The purified DNA solution was processed to a cycle sequencing using the DNA terminator cycle sequencing kit (PE Applied Biosystems, CA). Its nucleotide sequence was determined by an automatic DNA sequencer (Autosequencer 373S, PE Applied Biosystems, CA).
Statistics. The correlation coefficient (and equation) between the parasite density and MPH absorbance at 405 nm was obtained on a personal computer using SigmaPlot version 5.0 for Windows (SPSS Inc., Chicago, IL). The Student's t-test was applied to compare the observed data with the theoretical ones, and a value of P Ͻ 0.1 was considered significant.
RESULTS

Agarose gel electrophoretic patterns of PCR products.
The PCR products of the blood were amplified using the primer pair MPH-1 and MPH-2, and subjected to agarose gel electrophoresis. This revealed a prominent band at the 138 bp area in all of the parasite-proven patients (Figure 1 ). The band indicated the presence of malarial genes regardless of the species. On the other hand, no significant band was observed in the PCR products of the blood of the healthy controls or the post-treatment follow-up patients (Figure 1) .
Results of MPH. All the parasite-proven patients revealed strong positive reactions against only the P. vivax-specific probe ( Table 1 ). The absorbance of the reaction in OD was 1.30-1.90 (positive criterion ϭ 0.18) at 405 nm. However, none reacted positively against the probes specific for other species of malaria. In contrast, the post-treatment patients and healthy controls revealed negative reactions against the P. vivax-specific probe (OD: 0.07-0.11) as well as to other species-specific probes (OD: 0.07-0.09).
Parasite density in the blood and its correlation with the absorbance in MPH. The parasite density in the blood of 18 parasite-proven patients was between 94 and 7,222 per L blood (0.002% to 0.14% in parasitemia). The parasite density in the blood was positively correlated with the absorbance in the MPH following the equation Y ϭ 0.05X ϩ 1.40, where X is the parasite density in the logarithmic scale and Y is the OD in the MPH (Figure 2) . However, the degree of correlation was extremely low (r ϭ 0.408), and only a low-grade statistical significance was observed (0.05 Ͻ P Ͻ 0.10). The low correlation coefficient and low statistical significance were largely due to several patients who revealed a relatively low parasitemia despite high OD values.
Partial sequence of 18S rRNA of Korean P. vivax. The PCR products of the three patients' blood revealed very similar nucleotide sequences between the primer MPH-1 and MPH-2 regions of 18S rRNA of the Korean P. vivax ( Figure  3 ). The sequences of the primers MPH-1 and MPH-2 were identical to those in the blood (A-type) and mosquito (Ctype) stages of the typical P. vivax and other species of malaria. Comparing the other regions between the two primers (particularly the probe area) revealed no significant variation in the nucleotide sequence (Figure 3 ).
DISCUSSION
In order to cope with the disadvantages of the morphological and serological techniques for diagnosing malaria, various DNA assays have been introduced. [18] [19] [20] Simple, 18 double, 19 and nested PCR 20 amplifications of malarial DNA were reported as sensitive and specific diagnostic tools. However, these techniques required complicated and timeconsuming manipulations to extract the DNA and confirm the amplified products. As an alternative measure, the PCRbased MPH assay was tested for its practical utility and reported as a useful tool for the differential diagnosis of various species of malaria. [11] [12] [13] In the present study, we confirmed the usefulness and feasibility of the PCR-based MPH technique for the genetic diagnosis of the reemerging Korean P. vivax malaria. Using this technique it was possible to provide a specific diagnosis of human malaria. The technique was further suggested to be useful in evaluating the efficacy of the treatment, although the post-treatment testing could be done only in 4 of 18 patients. Sequencing of the probe region of 18S rRNA of Korean P. vivax revealed no significant variation from that of the typical P. vivax. 12, 13 The basic goal of the present study was to confirm whether the MPH technique is applicable to the reemerging Korean P. vivax malaria, since there could be variations in the sequence of the probe region of the malarial genes. An example of the variations in the probe region of 18S rRNA among malaria parasites was reported for P. ovale, which was found in Vietnam. 17 Genetic variations of Korean P. vivax have been strongly suggested because of its peculiar and atypical clinical manifestations (e.g., exceptionally long incubation periods, 3, 21, 22 atypical fever cycles, 3, 23 and higher frequency of relapses. 3, [21] [22] [23] [24] ). When human experimental infections were performed with the North Korean strain of P. vivax, 21 the incubation period was about one month in 25% of the patients and ranged between 5 and 13 months in the remaining 75% of the patients. The recent reemerging malaria is very similar in its incubation period. 3 The typical 48-hr fever cycle was observed in only 40% of the Korean tertian malaria patients. 23 In addition, the Korean P. vivax malaria showed higher frequencies of thrombocytopenia, leukopenia, elevation of transaminases, and low blood parasitemia compared with other geographical strains. 23, 25 Therefore, quite a few of the reemerging Korean malaria cases have been initially misdiagnosed as other febrile diseases and confirmed later as malaria. 26, 27 Although the probe region of the 18S rRNA of the Korean P. vivax showed no variations from the typical P. vivax, genetic variations at other regions should be investigated further.
The agarose gel electrophoretic patterns of the PCR products of the patients' blood showed successful amplification of the target area of 138 bp size in all of the parasite-proven patients. In contrast, there were no recognizable amplified products in any of the healthy controls and post-treatment follow-up patients. The disappearance of the band at the 138 bp area in the post-treatment patients suggests that the MPH technique could differentiate acute febrile cases of P. vivax from those in the convalescent stage. To verify this implication, however, studies dealing with sufficient numbers of post-treatment follow-up cases are required.
The MPH assay had been shown to be superior to the simple PCR assay because it could provide information on the severity of the infection. 13 The present study revealed a positive correlation between the parasite density in the blood and OD in the MPH assay. However, the degree of correlation and the statistical significance were both too low to draw definite conclusions.
Unfortunately, in the present study the lowest parasite density detectable by the MPH assay could not be determined due to the inadequate size of the sample population. It can be inferred, however, that in both the P. vivax and P. falciparum infections the MPH technique can detect as few as 1.3 parasites per L blood. 13 The cost of the MPH test is estimated roughly at US$3.00 per test, which is a little more expensive than examining a blood smear, but cheaper than treating a suspected malaria patient showing negative blood smears. In summary, the PCR-based MPH assay is a highly feasible tool for a DNA diagnosis of the Korean strain of P. vivax malaria.
